On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Victor J. Dzau

ResearcherPublications, citations & collaboration network

Victor J. Dzau is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Victor J. Dzau have?

ScholarIQindexed works

Victor J. Dzau has 701 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Victor J. Dzau have?

ScholarIQcitation count

Victor J. Dzau has 60,739 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Victor J. Dzau?

ScholarIQh-index

Victor J. Dzau has an h-index of 123 in OpenAlex.

What is the i10-index of Victor J. Dzau?

ScholarIQi10-index

Victor J. Dzau has an i10-index of 424 in OpenAlex.

What is the ORCID of Victor J. Dzau?

ScholarIQorcid

The ORCID for Victor J. Dzau is on the source record.

What is the OpenAlex record for Victor J. Dzau?

ScholarIQopenalex

The OpenAlex for Victor J. Dzau is on the source record.

What are the most-cited papers on Victor J. Dzau?

ScholarIQmost cited works
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts
Abeel A. Mangi, Nicolas Noiseux, Deling Kong, Huamei He, Mojgan Rezvani, Joanne S. Ingwall, Victor J. Dzau
Nature Medicine. 20031,510 Citations
The Heart in Hypertension
Edward D. Fröhlich, Carl S. Apstein, Aram V. Chobanian, Richard B. Devereux, Harriet P. Dustan, Victor J. Dzau, Fetnat Fauad-Tarazi, Michael J. Horan, Melvin L. Marcus, Barry M. Massie, Marc A. Pfeffer, Richard N. Ré, Edward J. Roccella, Daniel D. Savage, Clarence Shub
New England Journal of Medicine. 1992787 Citations
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors.
Masashi Mukoyama, Masatoshi Nakajima, Masatsugu Horiuchi, Hiroyuki Sasamura, Richard E. Pratt, Victor J. Dzau
Journal of Biological Chemistry. 1993768 CitationsOPEN ACCESS
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial
Michael J. Mann, Anthony D. Whittemore, Magruder C. Donaldson, Michael Belkin, Michael S. Conte, Joseph F. Polak, E. John Orav, Afshin Ehsan, Giorgio Dell’Acqua, Victor J. Dzau
The Lancet. 1999402 Citations
Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure
Victor J. Dzau, Wilson S. Colucci, Gordon H. Williams, Gregory Curfman, Leonard G. Meggs, Norman K. Hollenberg
New England Journal of Medicine. 1980379 Citations

Related on ScholarIQ

470M+ articles · free account